Search Results

Dual-epitope tagged constructs (N-term FLAG, C-term 1D4) Compatible with multiple readouts: proximity, immuno assays ______ Keyword Cloud : GPCR scientist network , GPCR online course , GPCR data platform , multiplex assays

The Tools to Detect Them Using the multiplexed GPCR library and Luminex assay , researchers can now: GPCR ecosystem , multiplex assays

ligand mechanism to the decisions that shape affinity, efficacy, selectivity, safety, and downstream assays That subtle distinction opened the door to a brand-new assay format. Instead of imaging-heavy workflows, pHSense offers a no-wash, plate-reader–ready, high-throughput assay Cleaner data:  higher signal-to-noise ratios sharpen CNS assays. Speed:  faster GPCR target validation and assay development.

Every day spent misunderstanding what your assays are truly showing you can lead to costly missteps—wasted Kenakin’s kinetic insights help you translate assay readouts into actionable knowledge that keeps your ’t Let Outdated Models Slow Your Next Program The analytical tools that shaped traditional affinity assays You’ll gain clarity that accelerates your path from discovery to clinic: Know when your assays truly

medicinal chemistry paved the way to co-founding Celtarys , a company now shaping the future of GPCR assay GPCR, is helping researchers worldwide gain access to customized, reliable assay tools without the delays

When assays behave unpredictably, the wrong interpretation doesn’t just waste time; it costs viable compounds Career opportunities:  Postdocs in GPCR biophysics and assay development; industry scientist roles at Protect your pipeline:  Misinterpreting displacement curves in allosteric assays means discarding viable Avoid costly blind spots:  Discover how G protein stoichiometry can dictate whether your assay informs—or

previous posts, CELT-335, one of our fluorescent compounds, was successfully employed in a binding assay very useful in GPCR drug discovery, starting from hit and lead validation all the way to pre-clinical assays Reduced background noise: Improvements in signal-to-noise ratio are key in CNS assays. Faster assay development: also speeds GPCR target validation. A Robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.

the biological environments they aim to represent. iPSC-derived cells, organoids, and biosensor-based assays pluripotent stem cells (iPSCs), iPSC-derived cardiomyocytes, organoid systems, and biosensor-based assays Discovery → Read DiscoverX article A2A Fluorescent Competitive Binding with NanoBRET® → Explore assay comprehensive reference on GPCR drug discovery project initiation, target selection, ligand characterization, assay

The first company to offer access to recombinant GPCR assays. Today, their catalogue includes over 1,000 functional assays representing more than 550 GPCR and other Montana Molecular Montana Molecular is a leader in advanced GPCR assay technologies and services, combining

You can have the most brilliant minds and cutting-edge assays, but if your science isn't continuously My work isn't just  about the latest and best assay; it's about the framework that ensures the right assay data leads to the right decision. We'll look at how overlooked operational details, such as misaligned data from diverse GPCR assay types

I call it the Lego Bucket Problem : You’ve got CRO output, internal assay data, maybe even some promising arrives too fast and too fragmented CROs deliver output without clear integration Teams chase the wrong assays Here’s what I bring: Biology-First Strategy I’ve designed GPCR assays, led collaborations across research

They design assays differently. They interpret deviations differently. Dual-assay strategies (high and low sensitivity) are essential, not optional. Assay Volume Control: Classification Through Contrast Sensitivity doesn’t merely change the size of the ligands from a single system: The same molecule can occupy different mechanistic categories across assay requires understanding where the ligand sits on the operational curve—not just where it sits in one assay

pipes instrument outputs into a central hub — where QC, analysis, consumption and consolidation across assays GPCR Drug Discovery The only way out for GPCR drug discovery programs isn’t more people or shinier assays The Hidden Costs of Poor Drug Discovery Data Management Stop pretending more hires or new assays will

Early In Vivo Wins the Race When is the right time to move beyond cell assays? In vitro work is invaluable for mechanistic understanding—assay volume control, expression system contrasts Modern real-time assays can deliver these insights earlier, faster, and cheaper than most teams assume Teams that proactively define experimental nuances early avoid receiving “perfectly executed wrong assays

Someone with strong assay development skills as well as strong data analysis and interpretation skills Mark:  “Are there particular assay types of interest?” Beth:  “We focus on biochemical, cell based, and radioligand binding assays to enable SAR, MOA, lead

Gαs slow conformational transition upon GTP binding and a novel Gαs regulator. FREE Symposium - IPI Surfacing (June 15, 2023) Training School on “Cell-based assays to study Adhesion

visualizing intermediate states with triple-color FRET, and deorphanizing targets using the new G(z)ESTY assay G(z)ESTY as an optimized cell-based assay for initial steps in GPCR deorphanization .  

Elements of a comprehensive and effective GPCR discovery Master advanced applications: Using new cellular assays codon-optimized clytin II gene in Chinese hamster ovary-K1 cells and its use in the G-protein-coupled receptor assays GPCR Events, Meetings, and Webinars September 18, 2024 | FREE Webinar - The value of GPCR cell-based assays

If you’re applying orthosteric logic to modulator-driven systems, you’re likely misreading your assays—and Binding assays  report on one set of receptor states. Functional assays  track another.

We are not measuring the same receptor in these assays. The consequences for assay interpretation are direct: Observed affinity changes reflect altered receptor ligand inadequacy In translational settings, this explains why compounds behave differently across assay For pharmacologists refining assay interpretation, for teams navigating conflicting data, and for leaders

the cell ✅ Tools for evaluating scaffold permeability using modern, cost-effective pharmacokinetic assays In a traditional assay, they look the same. But in vivo? The good news: we now have reliable, low-cost assays to find out —Kenakin walks through the essential

fluorescently labeled ligands and innovative chemical biology tools to support real-time, non-radioactive GPCR assays labeled ligands, with excellent affinity and pharmacological profiles, designed to advance GPCR-targeted assay

This emphasis may have caused other signaling pathways to be overlooked due to a need for adequate assay This further underscores the need for advanced assay technologies and a deep understanding of cellular Recently, several high-throughput screening (HTS) assays for ERK activation have been developed, each Each assay offers unique advantages for detecting ERK activation, contributing to the broader toolkit By understanding the intricacies of GPCR signaling and utilising advanced assay technologies, researchers

analogies (think batteries and balance scales), Terry reveals why different tissues—and even different assays—can

Whether you're heading into your first assay or trying to make sense of inconsistent data, Terry gives

information from binding experiments that advance your work efficiently ✅ Clarity that helps you move from assay Move Faster, Smarter, and with Confidence   When you understand what your assays are truly showing you

After all, a good tool makes a good assay, and a good assay improves research capacity.

activation state of G protein-coupled receptors are a useful addition to the molecular pharmacology assay the detection of both (partial) agonism and inverse agonism on living cells in a microplate reader assay better correlated with binding affinity values that were measured in radioligand competition binding assays biosensor in membranes might be a ready-to-use, high-throughput alternative for radioligand binding assays that in addition can also detect ligand efficacies with comparable values as the intact cell assay."

current study found that 133 of these receptors were also detected, highlighting the robustness of the assay previous study not detected in the current analysis, suggesting that variations in cell preparation and assay

to replace inference with models that disentangle mechanism—so your next go/no-go, dose range, and assay Engineer assays on purpose:  Set ranges, controls, and system sensitivity to surface mechanism—before Assay flexibility:  Combine self-labeling tags with quantitative readouts (e.g., TR-FRET) to expand mechanism